1. Introduction {#sec1-ijms-16-26021}
===============

*Hedyotis diffusa* (*H. diffusa*) Willd, an annual slender plant belong to *Rubiaceae*, is widely distributed in South of China, and other Asian country, such as Indonesia, Japan, Malaysia, Nepal, Philippines, Sri Lanka and Thailand \[[@B1-ijms-16-26021]\]. *H. diffusa* named "*Bai Hua She She Cao*" in Chinese, is a famous traditional Chinese Medicine and applied on treating bronchitis, arthritis, rheumatism, appendicitis, sore throat, urethral infection, contusions, ulcerations and extension of malignancies \[[@B2-ijms-16-26021]\]. Pharmacological studies show that *H. diffusa* has anticancer, anti-inflammatory, antioxidative, neuroprotective, hepatoprotective, anti-mutagenesis, and immunemodulating activities \[[@B2-ijms-16-26021],[@B3-ijms-16-26021],[@B4-ijms-16-26021],[@B5-ijms-16-26021],[@B6-ijms-16-26021]\]. Meanwhile, phytochemical studies have shown that the major constituents of *H. diffusa* are anthraquinones, flavonoids and iridoid glycosides \[[@B7-ijms-16-26021]\].

As known, the chemical constituents are responsible for the efficacy of herbal medicine. There are some investigations focused on traditional use of *H. diffusa* extract, the investigation on evaluating the anti-inflammatory effect and searching the anti-inflammatory constituents, especially for renal inflammation, have been rarely found during the past two decades. Clarifying which constituents absorbed into blood to produce anti-inflammatory effect plays a key role in clinical use of *H. diffusa*. However, the bioactive constituents are generally minor or trace after absorbed into blood. To elucidate the anti-inflammatory constituents from *H. diffusa*, the method that could improve resolution efficiency and enhance the signal response of minor/trace constituents should be used.

Ultra-fast liquid chromatography-diode array detector-quadrupole-time of flight mass spectrometry (UFLC-DAD-Q-TOF-MS/MS) is a very useful means for separation and identification of compounds from herbal extract and biological samples. The UFLC-DAD-Q-TOF-MS/MS method has been so far used to analyze the constituents in *H. diffusa* due to the high resolution and low detection limit \[[@B8-ijms-16-26021],[@B9-ijms-16-26021]\]. This method, however, has not been used for research on anti-inflammatory constituents of *H. diffusa* *in vivo*.

In the study, the protective effect of *H. diffusa* on anti-inflammation was evaluated using histological appearance and immunohistochemistry of renal sections from lipopolysaccharide (LPS)-induced renal inflammation mice model. The levels of pro-inflammatory cytokines, anti-inflammatory cytokine and chemokine in serum and renal tissues were detected to evaluate the anti-inflammatory effect of *H. diffusa*. Furthermore, to find out the potential bioactive constituents with anti-inflammatory effect, serum and renal chemical profiles of *H. diffusa* were studied by UFLC-DAD-Q-TOF-MS/MS method.

2. Results and Discussion {#sec2-ijms-16-26021}
=========================

2.1. Effect of Water Extract of H. diffusa on the Histology of LPS-Induced Renal Inflammation Mice {#sec2dot1-ijms-16-26021}
--------------------------------------------------------------------------------------------------

No histological changes were seen in renal section of the control group ([Figure 1](#ijms-16-26021-f001){ref-type="fig"}). In contrast, histological evaluation of renal sections from LPS-treated group revealed that necrotic epithelial cells, invasion of inflammatory cells in the interstitium and swelling glomeruli with decrease of capsular space. Comparing to LPS-treated group, the administration of low and medium doses of water extract of *H. diffusa* (1.25 and 2.5 g/kg body weight (bw)) partially prevented renal damage induced by LPS. The high dose (5.0 g/kg bw) could have better protection to the mice renal tissue from damage induced by LPS.

![Effect of *Hedyotis diffusa* extract in the LPS-treated mice: histological appearance of renal sections of mice treated with saline (**A**); LPS (**B**); low dose (1.25 g/kg body weight) (**C**); medium dose (2.5 g/kg bw) (**D**); and high dose (5.0 g/kg bw) (**E**) of water extract of *H. diffusa*. The renal sections were analyzed by PAS staining (magnification is 400×).](ijms-16-26021-g001){#ijms-16-26021-f001}

Macrophages involvement in LPS-induced renal damage was assessed, and therefore the glycoprotein CD68, one of important antigens for macrophage study, was examined after LPS-treated mice. As shown in [Figure 2](#ijms-16-26021-f002){ref-type="fig"}, CD68-positive macrophages were at low levels in control group. Compared with the after LPS-treated group, water extract of *H. diffusa* obviously reduced the CD68, indicating that the number of infiltrative macrophage was markedly inhibited after *H. diffusa* treatment.

![Effects of *H. diffusa* extract on the infiltration of macrophage in the kidneys: CD68 positive cells stained with immunohistochemistry are shown after treatment with (**A**) saline; (**B**) LPS; (**C**) low dose, 1.25 g/kg bw; (**D**) medium dose, 2.5 g/kg bw; and (**E**) high dose, 5.0 g/kg bw) (magnification is 200×).](ijms-16-26021-g002){#ijms-16-26021-f002}

2.2. Effect of Water Extract of H. diffusa on the Productions of Cytokines and Chemokines {#sec2dot2-ijms-16-26021}
-----------------------------------------------------------------------------------------

To elucidate the protective effect of *H. diffusa* on LPS-induced renal inflammation, the levels of important cytokines tumor necrosis factor-α (TNF-α), interleukin (IL)-1β, IL-6, and chemokine monocyte chemoattractant protein (MCP)-1 in serum and renal tissues were measured ([Figure 3](#ijms-16-26021-f003){ref-type="fig"}). Injection of LPS caused a significant increase in the levels of pro-inflammatory cytokines TNF-α, IL-1β, IL-6, and MCP-1 in serum and renal tissues and the level of anti-inflammatory cytokine IL-10 in renal tissues as compared with those in the control group. The administration of low dose of water extract of *H. diffusa* (1.25 g/kg bw) could decrease in the level of TNF-α in serum and renal tissues, and partially affect the factors in serum or renal tissues, including significant increase in the level of IL-10, decrease in the level of IL-6 in renal tissues and the level of MCP-1 in serum compared with that of the LPS-treated group. The medium dose treated group (2.5 g/kg bw) could significantly decrease the level of TNF-α, IL-1β and IL-6, and increase the level of IL-10 in serum and renal tissues; moreover, this dose (2.5 g/kg bw) could also significantly decrease the level of MCP-1 in serum when compared with that of the LPS-treated group. Treatment with high dose of *H. diffusa* (5.0 g/kg bw) could significantly decrease productions of TNF-α, IL-1β, IL-6, and MCP-1, and increased production of IL-10 as compared with those in the LPS-treated group, showing the dose-dependent manner. In addition, the high dose treated group showed no significant difference to the control group in the levels of TNF-α, IL-1β, IL-6, and MCP-1 in serum and renal tissues, while this group had significantly higher level of IL-10 than that of the control group.

![Effects of water extract of *H. diffusa* on the levels of TNF-α (**A**,**B**), IL-1β (**C**,**D**), IL-6 (**E**,**F**), IL-10 (**G**,**H**), and MCP-1 (**I**,**J**) in serum and renal tissue of mice. Results are expressed as means ± SD (*n* = 8). \* *p* \< 0.05, \*\* *p*\< 0.01 compared with LPS group; ^\#^ *p* \< 0.05, ^\#\#^ *p* \< 0.01 compared with control group.](ijms-16-26021-g003){#ijms-16-26021-f003}

2.3. Chemical Profiles of Water Extract of H. diffusa by UFLC-DAD-Q-TOF-MS/MS {#sec2dot3-ijms-16-26021}
-----------------------------------------------------------------------------

In this study, water extract of *H. diffusa* was detected both in positive ion mode and negative ion mode ([Figure 4](#ijms-16-26021-f004){ref-type="fig"}). The detailed information of 35 compounds has been listed in [Table 1](#ijms-16-26021-t001){ref-type="table"} and their chemical structures were shown in [Figure 5](#ijms-16-26021-f005){ref-type="fig"}. Simple peaks 1, 2, 3, 4, 5, 6, 7, 8, 11, 15, 24, 26 and 35 have unequivocally identified as deacetylasperulosidec acid, scandoside, geniposidic acid, scandoside methyl ester, asperulosidic acid, scopolin, asperuloside, *p*-courmaric acid, ferulic acid, rutin, quercetin, kaemperol and ursolic acid, respectively, by comparing their retention time, UV data, molecular weight and MS spectra with those of standards. The constituents that were with no referable standards have been tentatively characterized with UV data, molecular weight, and fragment behaviors in MS spectra and from the literature.

![Chromatograms of water extract of *H. diffusa*: (**A**) DAD chromatogram detected at 254 nm; (**B**) total ion chromatogram in positive ion mode; and (**C**) total ion chromatogram in negative ion mode). White arrow means DAD chromatogram (**A**) and the blue arrows means MS chromatogram in positive and negative ion mode (**B**,**C**).](ijms-16-26021-g004){#ijms-16-26021-f004}

###### 

Chemical structures of the compounds identified in *H. diffusa* extract, mice plasma and kidney.

![](ijms-16-26021-g005a)

![](ijms-16-26021-g005b)

Due to abundant capillary in mice abdomen, constituents in *H. diffusa* could be absorbed quickly and comprehensively by intraperitoneal injection. After deducting the matrix interference from control plasma and model plasma, most of these compounds, except peaks 6, 22, 23, 33 and 35, were also found in dosed plasma. However, only peaks 1, 2, 3, 4, 9, 10, 13, 14, 16, 18, 24, 26 and 27 were detected in kidney homogenate by XIC manager (Extract Ions Using Dialog). Peaks 31, 32, and 34 were found in bio-samples from control and model group as well as from dosed group. In view of the fragmentor rule, they were inferred as polyunsaturated fats compounds. The tentative identification of each components were outlined below.

6-*O*-*Z*-*p*-Coumaroyl scandoside methyl ester (peak 19) and 6-*O*-*E*-*p*-coumaroyl scandoside methyl ester (peak 20) were isomers with \[M − H\]^−^ ions at *m*/*z* 549.16274 and *m*/*z* 549.16396 (C~26~H~30~O~13~), respectively, in negative ion mode. Peaks 22 and 23 were identified as 6-*O*-*Z*-*p*-feruloyl scandoside methyl ester and 6-*O*-*E*-*p*-feruloyl scandoside methyl ester, 30 Da more than peak 19. The produced fragment ion at *m*/*z* 223, *m*/*z* 193, and *m*/*z* 119 from these four compounds were similar to scandoside methyl ester. It indicated that the four compounds were the derivatives of scandoside methyl ester, which is in accordance with previous literature \[[@B8-ijms-16-26021],[@B9-ijms-16-26021]\].

Flavonoids and its derivatives showed characteristic UV spectra and fragment rules in mass spectra under collision induced decomposition condition \[[@B10-ijms-16-26021],[@B11-ijms-16-26021]\]. The groups linked to aglycone, such as glucose, galactose and rhamnose, were always loss firstly and the deprotonated aglycone always had a high relative aboundance. Compounds 9 and 10 were a pair of isomers with the protonated molecular ions at *m*/*z* 627.15557 and *m*/*z* 627.15525 (C~27~H~30~O~17~), respectively, and similar fragmentations, showing the occurrence of two hexosyl residue. Referring to the literature \[[@B12-ijms-16-26021]\], they were tentatively identified as quercetin-3-*O*-sophoroside and quercetin-3-*O*-\[2-*O*-β-[d]{.smallcaps}-glucopyranosyl\]-β-[d]{.smallcaps}-galactopyranoside. Compound 12 gave protonated ion at *m*/*z* 597.14508 (C~26~H~28~O~16~). The MS/MS analyses showed the loss of 132 Da and 294 Da (132 + 162), suggesting the presence of xylose and glucose groups. Therefore, it was identified as quercetin-3-*O*-sambubioside in according with previous report \[[@B13-ijms-16-26021]\]. Compound 17 was characterized as quercetin-3-*O*-\[2-*O*-(6-*O*-*E*-sinapol)-β-[d]{.smallcaps}-glucopyranosyl\]-β-[d]{.smallcaps}-galactopyranoside with deprotonated molecular ion at *m/z* 831.19906 (C~38~H~40~O~21~), 206 Da higher than that of compound 10, suggesting that it was a sinapol derivated of 10 \[[@B9-ijms-16-26021],[@B13-ijms-16-26021]\]. In addition, the base peak at *m*/*z* 301.0344 demonstrated the presence of quercetin. Compound 18 gave deprodonated molecular ion at *m*/*z* 801.18894 (C~37~H~38~O~20~), with similar MS/MS spectra with compound 17. It was 30 Da less than that of compound 17, indicating the lack of a methoxyl group. Thus, it was tentatively characterized as quercetin-3-*O*-\[2-*O*-(6-*O*-*E*-feruloyl)-β-[d]{.smallcaps}-glucopyranosyl\]-β-[d]{.smallcaps}-galactopyranoside \[[@B12-ijms-16-26021]\]. Compounds 13, 14, 16 and 21 showed the characteristic MS fragmentation of kaempferol derivated. The loss of 324 Da (162 + 162) for 13 and 14, 306 Da (146 + 162) for 16 and 500 Da (176 + 162 + 162) indicated different groups linked to kaempferol aglycone. Because of the lack of more evidence, compounds 13 and 14 were tentatively characterized as Kaempferol-3-*O*-(2-*O*-β-[d]{.smallcaps}-glucopyranosyl)-β-[d]{.smallcaps}-galactopyranoside and its isomer \[[@B12-ijms-16-26021],[@B14-ijms-16-26021]\], and need to be confirmed by NMR. Compounds 16 and 21 were tentatively characterized as kaempferol-3-*O*-(6′′-*O*-[l]{.smallcaps}-rhamnosyl)-β-[d]{.smallcaps}-glucopyranoside and kaempferol-3-*O*-\[2-*O*-(6-*O*-E-feruloyl)-β-[d]{.smallcaps}-glucopyranosyl\]-β-[d]{.smallcaps}-galactopyranoside, respectively \[[@B12-ijms-16-26021],[@B15-ijms-16-26021]\].

ijms-16-26021-t001_Table 1

###### 

Chemical profiles in *H diffusa* by ultra-fast liquid chromatography-diode array detector-quadrupole-time of flight mass spectrometry.

  No.   Rt (min)   Molecular Formula   λmax (nm)   \[M + Na\]^+^      \[M + H\]^+^       \[M -- H\]^−^      Major Fragmentors in Positive Mode                                                                                                                                Major Fragmentors in Negative Mode                                                                                                                                                                                                                                                Identification                                                                                                         Source
  ----- ---------- ------------------- ----------- ------------------ ------------------ ------------------ ----------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------- ----------------------
  1     1.62       C~16~H~22~O~11~     239         413.10505 (−0.9)                      389.10862(−0.8)    395.0879 \[M+Na--H~2~O\]^+^, 251.0512 \[M+Na--glc\]^+^, 233.0420 \[M+H--glc\]^+^, 215.0299 \[M+H--glc--H~2~O\]^+^                                                 227.0579 \[M--H--glc\]^−^, 209.0468 \[M--H--glc--H~2~O\]^−^, 183.0683 \[M--H--glc--CO~2~\]^−^, 165.0573 \[M--H--glc--CO~2~--H~2~O\]^−^, 137.0616 \[M--H--glc--CO~2~--H~2~O--CO\]^−^                                                                                               Deacetylasperulosidic acid                                                                                             Herb, Plasma, Kidney
  2     2.50       C~16~H~22~O~11~     238         413.10505 (−0.9)                      389.10862 (−0.8)   395.0948 \[M+Na--H~2~O\]^+^, 233.0408 \[M+H--glc\]^+^                                                                                                             227.0588 \[M--H--glc\]^−^, 209.0473 \[M--H--glc--H~2~O\]^−^, 183.0679 \[M--H--glc--CO~2~\]^−^, 165.0573 \[M--H--glc--CO~2~--H~2~O\]^−^, 147.0464 \[M--H--glc--CO~2~--2H~2~O\]^−^, 139.0411 \[M--H--glc--2CO~2~\]^−^, 121.0302 \[M--H--glc--2CO~2~--H~2~O\]^−^, 89.0253, 59.0165   Scandoside                                                                                                             Herb, Plasma, Kidney
  3     3.01       C~16~H~22~O~10~     235         397.11053 (+0)                        373.11388 (−0.4)   235.0561 \[M+Na--glc\]^+^, 217.0439, 191.0673                                                                                                                     211.0620 \[M--H--glc\]^−^, 167.0707 \[M--H--glc--CO~2~\]^−^, 149.0606, 123.0453                                                                                                                                                                                                   Geniposidic acid                                                                                                       Herb, Plasma, Kidney
  4     3.38       C~17~H~24~O~11~     238         427.12095 (−0.3)                      403.12433 (−0.6)   265.0669 \[M+Na--glc\]^+^                                                                                                                                         241.0710 \[M--H--glc\]^−^, 223.0628 \[M--H--glc--H~2~O\]^−^, 209.0444 \[M--H--glc--CH~3~OH\]^−^, 193.0683, 191.0508, 167.0350, 139.0397                                                                                                                                           Scandoside methyl ester                                                                                                Herb, Plasma, Kidney
  5     3.60       C~18~H~24~O~12~     229         455.11562 (−0.8)                      431.11967 (+0.4)   437.1027 \[M+Na--H~2~O\]^+^, 293.0621 \[M+Na--glc\]^+^, 275.0518 \[M+H--glc--H~2~O\]^+^, 197.0191, 147.0430                                                       269.0669 \[M--H--glc\]^−^, 251.0588 \[M--H--glc--H~2~O\]^−^, 225.0792 \[M--H--glc--CO~2~\]^−^, 179.0566 \[M--H--glc--CO~2~--HCOOH\]^−^, 165.0573 \[M--H--glc--CO~2~--CH~3~COOH\]^−^, 121.0302 \[M--H--glc--2CO~2~--CH~3~COOH\]^−^, 89.0257, 59.0170                               Asperulosidic acid                                                                                                     Herb, Plasma
  6     3.98       C~16~H~18~O~9~      221, 320                       355.10270 (+1.0)   353.0881 (+0.8)    163.0384, 145.0238, 135.0442, 117.0343, 89.0398                                                                                                                   191.0552 \[M--H--glc\]^−^, 179.0341, 135.0446                                                                                                                                                                                                                                     Scopolin                                                                                                               Herb
  7     4.13       C~18~H~22~O~11~     238         437.10509 (−0.3)                      413.1085 (−0.9)    275.0542 \[M+Na--glc\]^+^, 187.0372, 147.0458                                                                                                                     251.0544 \[M--H--glc\]^−^, 205.0529 \[M--H--glc--HCOOH\]^−^, 191.0364 \[M--H--glc--CH~3~COOH\]^−^, 147.0457 \[M--H--glc--CH~3~COOH--CO~2~\]^−^, 119.0501 \[M--H--glc--CH~3~COOH--CO--CO~2~\]^−^                                                                                   Asperuloside                                                                                                           Herb, Plasma
  8     5.79       C~9~H~8~O~3~        219, 296                       165.05416 (−2.8)   163.04128 (7.4)    147.0435 \[M+H--H~2~O\]^+^, 119.049 \[M+H--HCOOH\]^+^, 91.0552, 77.0406, 65.0415                                                                                  119.0505 \[M--H--CO~2~\]^−^, 93.0355                                                                                                                                                                                                                                              *p*-Coumaric acid                                                                                                      Herb, Plasma
  9     5.85       C~27~H~30~O~17~     256, 355    649.1370 (−0.8)    627.15557 (+)      625.14120 (+0.3)   465.1052 \[M+H--glc\]^+^, 303.0490 \[M+H--2glc\]^+^                                                                                                               301.0383 \[M--H--2glc\]^−^, 271.0277 \[M--H--2glc--CH~2~O\]^−^                                                                                                                                                                                                                    Quercetin-3-*O*-sophoroside                                                                                            Herb, Plasma, Kidney
  10    5.99       C~27~H~30~O~17~     256, 355    649.1370 (-0.8)    627.15525 (−0.5)                      465.1021 \[M+H--gal\]^+^, 303.0493 \[M+H--gal--glc\]^+^                                                                                                           301.0317 \[M--H--gal--glc\]^−^, 271.0280 \[M--H--gal--glc--HCOH\]^−^                                                                                                                                                                                                              Quercetin-3-*O*-\[2-*O*-β-[d]{.smallcaps}-glucopyranosyl\]-β-[d]{.smallcaps}-galactopyranoside                         Herb, Plasma, Kidney
  11    6.92       C~10~H~10~O~4~      219                            195.06477 (−2.1)   193.05146 (+4.3)   177.0549 \[M+H--H~2~O\]^+^, 149.0523 \[M+H--HCOOH\]^+^ 145.0283, 89.0396                                                                                          149.0457 \[M--H--CO~2~\]^−^                                                                                                                                                                                                                                                       Ferulic acid                                                                                                           Herb, Plasma
  12    7.01       C~26~H~28~O~16~     264, 339    619.12649 (-0.8)   597.14508 (+0.1)   595.13022 (−0.4)   465.1011 \[M+H--xyl\]^+^, 303.0484 \[M+H--xyl--glc\]^+^                                                                                                           301.0341 \[M--H--xyl--glc\]^−^, 271.0246 \[M--H--xyl--glc--CH~2~O\]^−^                                                                                                                                                                                                            Quercetin-3-*O*-sambubioside                                                                                           Herb, Plasma
  13    7.27       C~27~H~30~O~16~     265, 344    633.14211 (−0.8)   611.16075 (+0.1)   609.14959 (+5.6)   449.1062 \[M+H--glc\]^+^, 287.0540 \[M+H--glc--gal\]^+^, 163.0598                                                                                                 285.0348 \[M--H--glc--gal\]^−^, 255.0320 \[M--H--glc--gal--CH~2~O\]^−^                                                                                                                                                                                                            Kaempferol-3-*O*-(2-*O*-β-[d]{.smallcaps}-glucopyranosyl)-β-[d]{.smallcaps}-galactopyranoside or isomer                Herb, Plasma, Kidney
  14    7.57       C~27~H~30~O~16~     264, 340    633.14211 (−0.8)   611.16069 (0)      609.15134 (+8.6)   449.1081 \[M+H--glc\]^+^, 287.0541 \[M+H--glc--gal\]^+^, 145.0482                                                                                                 285.0434 \[M--H--glc--gal\]^−^, 255.0320 \[M--H--glc--gal--CH~2~O\]^−^                                                                                                                                                                                                            Kaempferol-3-*O*-(2-*O*-β-[d]{.smallcaps}-glucopyranosyl)-β-[d]{.smallcaps}-galactopyranoside or isomer                Herb, Plasma, Kidney
  15    8.31       C~27~H~30~O~16~     265, 340    633.14211 (−0.8)   611.16069 (0)      609.15128 (+8.5)   465.1016 \[M+H--rha\]^+^, 303.0489 \[M+H--rha--glc\]^+^                                                                                                           301.0377 \[M--H--rha--glc\]^−^                                                                                                                                                                                                                                                    Rutin                                                                                                                  Herb, Plasma
  16    9.39       C~27~H~30~O~15~     265, 340                       595.16572 (0)      593.15110 (-0.2)   449.1026 \[M+H--rha\]^+^, 287.0548 \[M+H--rha--glc\]^+^                                                                                                           285.0459 \[M--H--rha--glc\]^−^                                                                                                                                                                                                                                                    Kaempferol-3-*O*-(6′′-*O*-L-rhamnosyl)-β-[d]{.smallcaps}-glucopyranoside                                               Herb, Plasma, Kidney
  17    10.92      C~38~H~40~O~21~     265, 338    855.19472 (−0.8)   833.21331 (−0.2)   831.19906 (+0.2)   465.1032303.0499 \[M+H--sinapol--glc\]^+^, 303.0499 \[M+H--sinapol--glc-gal\]^+^, 177.0489                                                                        625.1414 \[M--H--sinapol\]^−^, 301.0344 \[M--H--sinapol--glc--gal\]^−^, 271.0250                                                                                                                                                                                                  Quercetin-3-*O*-\[2-*O*-(6-*O*-*E*-sinapol)-β-[d]{.smallcaps}-glucopyranosyl\]-β-[d]{.smallcaps}-galactopyranoside     Herb, Plasma
  18    11.54      C~37~H~38~O~20~     254, 336    825.18454 (−0.4)   803.20329 (+0.2)   801.18894 (+0.7)   303.0493 \[M+H--feruloyl--glc-gal\]^+^, 177.0539                                                                                                                  625.1477 \[M--H--feruloyl\]^−^, 301.0391 \[M--H--feruloyl--glc--gal\]^−^, 271.0285                                                                                                                                                                                                Quercetin-3-*O*-\[2-*O*-(6-*O*-*E*-feruloyl)-β-[d]{.smallcaps}-glucopyranosyl\]-β-[d]{.smallcaps}-galactopyranoside    Herb, Plasma, Kidney
  19    12.16      C~26~H~30~O~13~     309         573.15785 (+0)     551.17641 (+0.9)   549.16274 (+2.5)                                                                                                                                                                     369.1011 \[M--H--glc--H~2~O\]^−^, 223.0634 \[M--H--glc--H~2~O--cou\]^−^, 193.0552, 191.0369, 163.0409, 119.0519                                                                                                                                                                   6-*O*-*Z*-*p*-coumaroyl scandoside methyl ester                                                                        Herb, Plasma
  20    12.64      C~26~H~30~O~13~     309         573.15785 (+0)     551.17589 (0)      549.16396 (+4.7)   225.0723 \[M+H--glc--H~2~O--cou\]^+^                                                                                                                              369.0978 \[M--H--glc--H~2~O\]^−^, 223.0616 \[M--H--glc--H~2~O--cou\]^−^, 193.0547, 191.0361, 163.0403, 119.0510                                                                                                                                                                   6-*O*-*E*-*p*-coumaroyl scandoside methyl ester                                                                        Herb, Plasma
  21    12.78      C~37~H~38~O~19~     268, 328    809.18960 (−0.4)   787.20863 (+0.8)   785.19407 (+0.8)   449.1072 \[M+H--fer--glc\]^+^, 287.0553 \[M+H--fer--glc--gal\]^+^, 177.0542, 145.0275                                                                             609.1492 \[M--H--fer\]^−^, 429.0849 \[M--H--fer--glc--H~2~O\]^−^, 285.0431 \[M--H--fer--glc--gal\]^−^, 255.0303, 227.0367                                                                                                                                                         Kaempferol-3-*O*-\[2-*O*-(6-*O*-*E*-feruloyl)-β-[d]{.smallcaps}-glucopyranosyl\]-β-[d]{.smallcaps}-galactopyranoside   Herb, Plasma
  22    12.87      C~27~H~32~O~14~     299         603.16862 (+0.3)   581.1864 (−0.2)    579.17408 (3.7)                                                                                                                                                                      399.1111 \[M--H--glc--H~2~O\]^−^, 223.0617 \[M--H--fer--glc--H~2~O\]^−^, 193.0532, 191.0377, 134.0391, 119.0350                                                                                                                                                                   6-*O*-*Z*-*p*-feruloyl scandoside methyl ester                                                                         Herb
  23    13.26      C~27~H~32~O~14~     299         603.16862 (+0.3)   581.18627 (−0.4)   579.17283 (+1.5)                                                                                                                                                                     399.1083 \[M--H--glc--H~2~O\]^−^, 223.0622 \[M--H--fer--glc--H~2~O\]^−^, 193.0518, 191.0375, 134.0382, 119.0348                                                                                                                                                                   6-*O*-*E*-*p*-feruloyl scandoside methyl ester                                                                         Herb
  24    14.64      C~15~H~10~O~7~      254, 370                       303.04973 (−0.7)   301.03565 (+0.9)   285.0385 \[M+H--H~2~O\]^+^, 229.0479 \[M+H--H~2~O--2CO\]^+^, 177.0543, 153.0176                                                                                   286.0583 \[M--H--CH~3~\]^−^, 179.0001, 151.0058                                                                                                                                                                                                                                   Quercetin                                                                                                              Herb, Plasma, Kidney
  25    14.78      C~16~H~12~O~5~                                     285.07565 (−0.3)   283.06143 (+0.8)   267.0651 \[M+H--H~2~O\]^+^, 239.0722 \[M+H--H~2~O--CO\]^+^, 209.0580 \[M+H--H~2~O--CO--HCOH\]^+^, 181.0650 \[M+H--H~2~O--2CO--HCOH\]^+^, 153.0697                 268.0399 \[M--H--CH~3~\]^−^ , 239.0364 \[M--H--CO~2~\]^−^, 211.0432 \[M--H--CO~2~--CO\]^−^, 195.0471 \[M--H--2CO~2~\]^−^                                                                                                                                                          2,6-Dihydroxy-3-methyl-4-methoxyanthraquinone or isomer                                                                Herb, Plasma
  26    15.01      C~15~H~10~O~6~      260, 370                       287.0548           285.04049 (+0.1)   165.0170, 153.0170, 121.0274                                                                                                                                      179.0001 \[M--H--2CO~2~\]^−^, 151.0025, 107.0129, 121.0284                                                                                                                                                                                                                        Kaempferol                                                                                                             Herb, Plasma, Kidney
  27    15.98      C~15~H~10~O~4~                                     255.06504 (−0.6)   253.05088 (+1.0)   227.0675 \[M+H--CO\]^+^, 209.0570 \[M+H--CO--H~2~O\]^+^, 199.0738 \[M+H--2CO\]^+^, 171.0792 \[M+H--3CO\]^+^, 153.0678 \[M+H--3CO--H~2~O\]^+^                      224.0497 \[M+H--CHO\]^−^, 183.0670 \[M+H--CHO--CH~3~CO\]^−^                                                                                                                                                                                                                       1-Methoxy-2-hydroxyanthraquinone                                                                                       Herb, Plasma, Kidney
  28    16.17      C~16~H~12~O~5~                                     285.07548 (−1.0)   283.05952 (−5.9)   270.0544 \[M+H--CH~3~\]^+^, 252.0400 \[M+H--CH~3~--H~2~O\]^+^, 224.0463 \[M+H--CH~3~--H~2~O--CO\]^+^ 196.0500 \[M+H--CH~3~--H~2~O--2CO\]^+^, 168.0568, 139.0521   268.0376 \[M--H--CH~3~\]^−^, 253.0146 \[M+H--HCOH\]^−^, 240.0432 \[M--H--CH~3~--CO\]^−^, 225.0202 \[M+H--HCOH--CO\]^−^, 212.0451 \[M--H--CH~3~--2CO\]^−^, 197.0311 \[M+H--HCOH--2CO\]^−^, 184.0539, 169.0316                                                                      2,6-Dihydroxy-3-methyl-4-methoxyanthraquinone or isomer                                                                Herb, Plasma
  29    16.93      C~16~H~12~O~4~                                     269.08036 (−1.8)   267.06684 (+2.1)   254.0562 \[M+H--CH~3~\]^+^, 226.0610 \[M+H--CH~3~--CO\]^+^, 197.0582 \[M+H--CH~3~--CO--CHO\]^+^, 181.0636, 152.0609                                               252.0534 \[M+H--CH~3~\]^−^, 224.0485 \[M+H--CH~3~--CO\]^−^                                                                                                                                                                                                                        1-Methoxy-2-hydroxy-3-methylanthraquinone                                                                              Herb, Plasma
  30    17.53      C~16~H~12~O~5~                                     285.0754           283.06143 (+0.8)   270.0521 \[M+H--CH~3~\]^+^, 242.0551 \[M+H--CH~3~--CO\]^+^, 214.0610 \[M+H--CH~3~--2CO\]^+^ 187.0594, 169.0646                                                    268.0376 \[M--H--CH~3~\]^−^, 240.0432 \[M--H--CH~3~--CO\]^−^, 212.0451 \[M--H--CH~3~--2CO\]^−^                                                                                                                                                                                    2,6-Dihydroxy-3-methyl-4-methoxyanthraquinone or isomer                                                                Herb, Plasma
  31    18.21      C~18~H~28~O~2~                                     277.21599 (−0.8)   275.20167 (+0.1)   259.2041, 235.1693, 171.1151, 149.1311, 135.1159, 121.1088, 107.0859, 93.0709, 79.0561                                                                            231.2161 \[M--H--CO~2~\]^−^                                                                                                                                                                                                                                                       Unidentified                                                                                                           Herb, Plasma, Kidney
  32    18.56      C~18~H~30~O~2~                                     297.23200 (+0.5)   277.21874 (+5.2)   261.2217, 243.2109, 223.1691, 187.1478, 173.1321, 151.1482, 137.1328, 123.1172, 109.1021, 95.0807, 81.0720                                                                                                                                                                                                                                                                                                                                          Unidentified                                                                                                           Herb, Plasma, Kidney
  33    19.07      C~19~H~26~O~5~                  357.16079 (−0.4)   335.18563 (+1.0)                      163.0751, 145.0643, 115.0543, 91.0555, 71.0515                                                                                                                                                                                                                                                                                                                                                                                                      Unidentified                                                                                                           Herb
  34    20.13      C~18~H~30~O~2~                                     279.23202 (+0.6)   277.21874 (+5.2)   261.2214, 243.2105, 223.1696, 187.1479, 173.1322, 151.1470, 137.1321, 123.1173, 109.1020, 95.0867, 81.0716, 67.0572                                               259.2064 \[M--H--H~2~O\]^−^, 233.2282 \[M--H--CO~2~\]^−^                                                                                                                                                                                                                          Unidentified                                                                                                           Herb, Plasma, Kidney
  35    20.68      C~30~H~48~O~3~                                     457.36734 (−0.6)   455.35279 (−0.6)   439.3564, 411.3615, 393.3508, 341.2846, 315.2694, 297.2575, 249.1844, 231.2106, 203.1791, 163.1476, 149.1316, 121.1009, 95.0863, 81.0713                          407.3300 \[M--H--HCOOH\]^−^                                                                                                                                                                                                                                                       Ursolic acid                                                                                                           Herb

As shown in [Figure 3](#ijms-16-26021-f003){ref-type="fig"}, anthraquinone compounds did not showed obviously UV absorption in DAD spectra, but with good mass response in positive ion mode. They were always characterized by losses of CH~3~ (15 Da) CO (28 Da), H~2~O (18 Da), and HCOH (30 Da). Compounds 25, 28 and 30 gave the same protonated molecular ion at *m/z* 285 in positive ion mode and *m*/*z* 283 in negative ion mode, with molecular formula of C~16~H~12~O~5~. The losses of neutral ions of 18 Da, 28 Da and 30 Da in MS spectra showed anthraquinone compounds characteristics. Thus they were identified as 2,6-Dihydroxy-3-methyl-4-methoxyanthraquinone or its isomer referring to previous report \[[@B16-ijms-16-26021]\], and were necessary to be confirmed by NMR. Compound 27 gave protonated ion at *m*/*z* 255.06504 (C~15~H~10~O~4~), and 30 Da less than compound 25, suggesting the lack of methoxy group. Compound 29 showed molecular formula of C~16~H~12~O~4~ with the protonated ion at 269.08036, and 14 Da more than compound 27 suggested the presence of methyl group. In according with the report \[[@B17-ijms-16-26021],[@B18-ijms-16-26021]\], compounds 27 and 29 were identified as 1-methoxy-2-hydroxyanthraquinone and 1-methoxy-2-hydroxy-3-methylanthraquinone, respectively.

2.4. Discussion {#sec2dot4-ijms-16-26021}
---------------

LPS as an important inflammatory factor, could induce endotoxemia, shock and multiple organ dysfunction syndromes. During LPS-induced inflammatory process, multiple endogenous inflammatory mediators were produced in response to LPS, and the immune responses and organic functions were modulated \[[@B19-ijms-16-26021],[@B20-ijms-16-26021],[@B21-ijms-16-26021]\]. The inflammatory model induced by LPS was commonly used to investigate the effect of herbal medicines and its bioactive constituents on renal inflammation \[[@B21-ijms-16-26021],[@B22-ijms-16-26021],[@B23-ijms-16-26021],[@B24-ijms-16-26021]\]. In various acute and chronic renal inflammations, renal tubular epithelial cells actively participate in the process of glomerular sclerosis and renal fibrosis via producing all kinds of inflammatory cytokines, chemokines and extracellular matrix \[[@B25-ijms-16-26021]\]. It has been reported that macrophages are involved in the productions of pro-inflammatory cytokines \[[@B26-ijms-16-26021]\]. Macrophage infiltration is considered to be a hallmark of all kinds of injury, and macrophage infiltration into the kidney is found as one of the initial events of renal disease \[[@B27-ijms-16-26021]\]. In this study, the results of histological and *immunohistochemical* examination of renal section clearly showed the evidence that *H. diffusa* extract had protective effect against renal inflammation induced by LPS, at the dose-dependent manner.

TNF-α, as the pro-inflammatory cytokine, activates other cytokines and therefore plays an important role in the pathogenesis of LPS-induced renal damage. A way to protect against LPS-induced inflammation is to inhibit TNF-α action \[[@B28-ijms-16-26021],[@B29-ijms-16-26021]\]. Similarly, IL-1β could also stimulate the production of other pro-inflammatory cytokines, such as IL-6 \[[@B30-ijms-16-26021],[@B31-ijms-16-26021]\]. It is thought that increasing production of IL-1β in renal tissues indicates the pathological development of inflammation, while increasing production of IL-6 is involved in the chronic processes and can suppress the synthesis of IL-1β in the second phase of the inflammatory response \[[@B32-ijms-16-26021]\]. *H. diffusa* could down-regulate the levels of pro-inflammatory cytokines in serum and renal tissue, therefore markedly ameliorating the local immune response induced by LPS. Moreover, TNF-α stimulates the production of chemokines, such as MCP-1. MCP-1 is chemotactic for multiple leukocytes, including neutrophils, monocytes and natural killer cells \[[@B33-ijms-16-26021],[@B34-ijms-16-26021]\]. The anti-inflammatory cytokine IL-10, which suppresses the production of pro-inflammatory cytokines and chemokines mainly through inhibition of innate immune cell activation, was up-regulated and therefore ameliorated LPS-induced renal damage in animal models \[[@B35-ijms-16-26021]\]. The inflammatory reaction was evaluated by the production levels of pro-inflammatory cytokines, anti-inflammatory cytokine and chemokine in serum and renal tissues. The results demonstrated that water extract of *H. diffusa* could dose-dependently attenuate the levels of TNF-α, IL-1β, IL-6, MCP-1, and IL-10, which are associated with the improvement of function in nephropathy tissues.

A series of studies showed that flavonoids, iridoids and anthraquinones from herbal medicine have anti-inflammatory effect \[[@B36-ijms-16-26021],[@B37-ijms-16-26021],[@B38-ijms-16-26021],[@B39-ijms-16-26021],[@B40-ijms-16-26021],[@B41-ijms-16-26021]\]. Kaempferol could suppress the activation of inflammatory nuclear factor-κB (NF-κB) transcription factor through nuclear factor-inducing kinase/I κB kinase and mitogen-activated protein kinase (MAPK) in aged rat kidney \[[@B42-ijms-16-26021]\]. Quercetin had the ability to attenuate activation of NF-κB and inhibited IL-1-triggered MCP-1 expression via suppression of NF-κB \[[@B43-ijms-16-26021]\]. Rutin, a quercetin glycoside, attenuated renal inflammation and apoptosis by reducing NF-κB, TNF-α and caspase-3 expression \[[@B44-ijms-16-26021]\]. The 5-glucoside of quercetin named saxifragin exerted anti-inflammatory activity by inhibiting NF-κB, caspase-1, and MAPK activation \[[@B45-ijms-16-26021]\]. Emodin, an anthraquinone derivative could activate peroxisome proliferator-activated receptor γ (PPAR-γ), and inhibit TLR2-mediated NF-κB signal pathway, thereby contributing to the immune inflammation regulation of emodin in LPS-induced acute kidney injury \[[@B46-ijms-16-26021],[@B47-ijms-16-26021]\]. Iridoid glycosides possessed anti-inflammatory and immunomodulatory effects by suppressing transmembrane signal transmission in NF-κ Bp65 pathway, decreasing the expressions of MCP-1 and α-smooth muscle actin (α-SMA) to modulate the productions of pro-inflammatory mediators in nephropathy tissue \[[@B48-ijms-16-26021],[@B49-ijms-16-26021],[@B50-ijms-16-26021]\]. The studies showed that inhibition of inflammatory response and induction of apoptotic signal via natural products could be useful approaches for prevention and cure of LPS-induced renal damage. In this study, the chemical profiles indicated that water extract of *H. diffusa* mainly contained these three chemotypes by UPLC-DAD-Q-TOF-MS/MS method. As high doses of extract of *H. diffusa* obviously protected renal tissues, suppressed the productions of the anti-inflammatory cytokines and chemokine, and promoted the production of anti-inflammatory cytokine, chemical profiles of the absorbed constituents of *H. diffusa* were necessary to elucidate the effective compounds *in vivo*. In the study, there were ten iridois, eleven flavonoids and five anthraquinones found in serum from the *H. diffusa* extract treatment groups. Moreover, the flavonoids, including kaempferol, quercetin, three kaempferol glycosides and three quercetin glycosides, were the most chemotype found in nephropathy tissues, indicating that flavonoids might target on the nephropathy tissues and greatly contribute to the suppression of inflammation process. Four iridois and one anthraquinone found in renal tissues suggested that these constituents might also have anti-inflammatory effect. The results of chemical study indicated that flavonoids, iridoids and anthraquinones might be responsible for the anti-inflammatory effect of *H. diffusa* and therefore could ameliorate the renal function and regulate the levels of the cytokines and chemokines through anti-inflammatory responses. However, the quantification of potential bioactive constituents and the method validation are not performed due to lacks of two-third of commercial standards, including three iridois, nine flavonoids, five anthraquinones and three unidentified compounds. Isolation and structural identification of non-commercial potential bioactive constituents from *H. diffusa* are undergoing in order to exactly identify and completely quantify all potential bioactive constituents in serum and renal tissues. In addition, the molecular pathway and anti-inflammatory mechanism of *H. diffusa* extract are still unclear, and thus further study is required according to the previous reports and these results.

3. Experimental Section {#sec3-ijms-16-26021}
=======================

3.1. Plant Material {#sec3dot1-ijms-16-26021}
-------------------

The materials of *H. diffusa* were collected from Guangzhou Qingping Herbal Market, Guangzhou, China. The materials were authenticated by the authors and dried at room temperature. The materials were stored in Guangzhou Institute of Advanced Technology, Chinese Academy of Sciences, Guangzhou, China.

3.2. Chemicals and Reagents {#sec3dot2-ijms-16-26021}
---------------------------

Deacetylasperulosidec acid, scandoside, geniposidic acid, scandoside methyl ester, asperulosidic acid, scopolin and asperuloside were purchased from Chengdu Biopurify Technology Development Co., Ltd. (Chengdu, China). *p*-courmaric acid, ferulic acid, rutin, quercetin, kaempferol, ursolic acid were from National Institutes for food and drug control (Beijing, China). HPLC-grade methanol was purchased from Fisher Scientific (Pittsburgh, PA, USA). Distilled water was purified by a Milli-Q system (Millipore, Milford, MA, USA). Other reagents were analytical grade.

3.3. Sample Preparation {#sec3dot3-ijms-16-26021}
-----------------------

Thirteen standards for the identification were prepared in HPLC-grade methanol to obtain the standard solutions of deacetylasperulosidec acid (0.17 μg/mL), scandoside (0.21 μg/mL), geniposidic acid (0.20 μg/mL), scandoside methyl ester (0.19 μg/mL), asperulosidic acid (0.20 μg/mL), scopolin (0.18 μg/mL), asperuloside (0.20 μg/mL), *p*-courmaric acid (0.20 μg/mL), ferulic acid (0.19 μg/mL), rutin (0.21 μg/mL), quercetin (0.21 μg/mL), kaempferol (0.20 μg/mL), and ursolic acid (0.19 μg/mL), respectively. All standard solutions were stored at 4 °C until used.

The dried *H. diffusa* were cut into 1 cm pieces, weighed (100 g) and boiled in 1 L water for 1 h; after filtration, the extraction was repeated twice; the combined filtrates were evaporated in vacuum at 70 °C (EYELA N-1001, Tokyo, Japan). The concentrated solution (100 mL) was added to ethanol (300 mL) and stored at 4 °C overnight; after filtration, ethanol in the solution was evaporated at 50 °C; and, finally, 100 mL of a brown, concentrated extract (equal to 1.0 g raw material/mL) were obtained and stored at 4 °C until used.

3.4. Animals and Experiment Design {#sec3dot4-ijms-16-26021}
----------------------------------

Kunming mice in the body weights of 18--20 g were purchased from the Experimental Animal Center of Southern Medical University (Guangzhou, China). Mice were fed on standard laboratory diet and water at *libitum*, and kept in 12 h dark/light cycle room at 21 ± 5 °C with a relative humidity of 55% ± 10% for one week before used. All experimental protocols were approved by the Animal Care and Use Committee of Southern Medical University (No. 2014A03031028, Guangzhou, China).

Mice were randomly divided into 5 groups (*n* = 8). In a week, the control group and the model group was injected intraperitoneally with sterile physiological saline (0.2 mL/20g bw, i.p. (intraperitoneal injection)); the treatment groups received the water extract of *H. diffusa* (equal to 1.25, 2.5 or 5.0 g/kg bw, i.p.). Except for the control group, the other four groups were injected intraperitoneally with LPS (3 mg/kg bw) after the sample injection on the fifth day. LPS injection was continued for three consecutive days. On the seventh day, all mice from each group were anesthetized by ether after LPS injection. Blood samples were taken from abdominal aorta. The serum was obtained by centrifugation at 13,000× *g* at 4 °C for 10 min and stored at −80 °C until analysis. After kidneys were removed carefully, one kidney was fixed with 10% formaldehyde for histological and immunohistochemical examinations, and the other one was frozen in liquid nitrogen for subsequent analysis. The frozen kidney was homogenized in ice-cold Tris--HCl buffer (pH = 7.4) containing protease inhibitors. The homogenized samples were centrifuged at 13,000× *g* at 4 °C for 20 min. The supernatants were collected and frozen at −80 °C until assay.

3.5. Preparation of Bioanalytical Samples {#sec3dot5-ijms-16-26021}
-----------------------------------------

An aliquot of 160 μL of combined plasma (20 μL per mouse) was mixed with 600 μL acetonitrile and vortexed for 1 min. After centrifuging at 13,000× *g* at 4 °C for 30 min, the supernatant was transferred into a fresh tube and evaporated with nitrogen. The residue dissolved in a 160 μL mobile phase was vortexed for 3 min and centrifuged at 13,000× *g* for 30 min. Finally, an aliquot of 10 μL of the supernatant were injected into the UFLC/DAD/Q-TOF-MS/MS system. An aliquot of 160 μL of mixed kidney supernatants (20 μL per mouse) was prepared as same method as the combined plasma.

3.6. Bioanalytical Method {#sec3dot6-ijms-16-26021}
-------------------------

UFLC analysis was performed on a Shimadzu UFLC XR instrument (Shimadzu Corp., Kyoto, Japan), consisting of a binary pump, an autosampler, a column oven and a diode-array detector. Samples were separated on a Phenomenex Kinetex column (2.1 mm i.d. (internal diameter) × 100 mm, 2.6 μm, Phenomenex, CA, USA). The mobile phase consisted of water (A) and methanol (B) both containing 0.1% formic acid (*v*/*v*) using a gradient elution program of 13% B (0--2 min), 13%--15% B (2--8 min), 15%--23% B (8--12 min), 23%--98% B (12--20 min) and 98% B (20--25 min). A 2-min post-run time was set to equilibrate the column. The flow rate was kept at 0.3 mL/min. The injected volume was 2 μL and the column temperature was set at 40 °C. The DAD detector scanned from 190 to 400 nm. Mass spectrometry was performed on the Triple TOF™ 5600 plus (AB SCIEX, Foster City, CA, USA) a hybrid triple quadrupole time-of-flight mass spectrometer equipped with ESI source. The system was operated with Analyst^®^ TF 1.6 software (AB SCIEX, Foster City, CA, USA). The conditions of MS/MS detector were as follows: ion source gas 155 psi; ion source gas 255 psi; curtain gas 30 psi; Source temperature 550 °C; ion spray voltage floating 4500 V; collision energy 35 V; collision energy spread 15 V; declustering potential 80 V. TOF-MS range was set at *m*/*z* 100--1000 and product ions mass range was set at *m*/*z* 50--1000. Both positive and negative ion modes were used for compounds ionization. Nitrogen was used as nebulizer and auxiliary gas.

The UFLC-DAD-Q-TOF-MS/MS data of samples were extracted and analyzed by PeakView software (AB SCIEX, Foster City, CA, USA), mainly with the XIC manager tool that provided the quasi-molecular weight, mass errors and isotope pattern fit. The predicted formula with errors less than ± 5 ppm was applied to compare with that of the compounds reported in Rubiaceae. The tentative identification of each compound was further guided by MS/MS spectrum (AB SCIEX, Foster City, CA, USA) that could determine the possible elemental compositions of the fragment ions and propose the fragmentation pathways.

3.7. Histological Examination {#sec3dot7-ijms-16-26021}
-----------------------------

Kidneys were fixed with 10% formalin for 24 h in a shaker and embedded in paraffin. The paraffin blocks were cut into 4-μm-thick sections using a microtome and then stained with periodic acid-Schiff (PAS) reagents for histological examination. Renal sections were evaluated at 400× magnification.

3.8. Immunohistochemical Examination {#sec3dot8-ijms-16-26021}
------------------------------------

After embedded renal tissues were deparaffinised in xylene and rehydrated, and the immunohistochemical examination was performed according to the manufacturer's instruction (GTVisionTMI Detection System, Gene Tech, Shanghai, China). Eight random fields were chosen and evaluated at 200× magnifications.

3.9. Determination of Cytokines {#sec3dot9-ijms-16-26021}
-------------------------------

Concentrations of TNF-α, IL-1β, IL-6, IL-10 and MCP-1 in serum and renal tissues were determined using mouse-specific enzyme-linked immunosorbent assay (ELISA) kits (NeoBioscience, Shenzhen, China). Each analysis was performed according to the manufacturer's instruction, and the concentrations of cytokines were calculated according to the standard curves.

3.10. Statistical Analysis {#sec3dot10-ijms-16-26021}
--------------------------

Results were shown as mean ± standard deviation (SD) for each experiment. The data obtained were analyzed using one-way analysis of variance (ANOVA) followed by Tukey's multiple comparison test (SPSS version 19.0, IBM, New York, NY, USA). A *p* value \<0.05 was considered as significant difference.

4. Conclusions {#sec4-ijms-16-26021}
==============

In this study, the results showed that water extract of *H. diffusa* could protect against the renal damage induced by LPS through down-regulating the levels of TNF-α, IL-1β, IL-6, and MCP-1, as well as up-regulating the level of anti-inflammatory cytokine IL-10. It also demonstrated that the main constituents, flavonoids, iridoids and anthraquinones, were possibly responsible for the anti-inflammatory effect of *H. diffusa*.
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